HomeGilead buys out rights to cancer therapy from Jounce for $67 millionFILE PHOTO: The logo of Gilead Sciences Inc pharmaceutical company

FILE PHOTO: The logo of Gilead Sciences Inc pharmaceutical company

FILE PHOTO: The logo of Gilead Sciences Inc pharmaceutical company is seen in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake

Most Read

How Trump’s Pentagon pick Hegseth fell out of love with the U.S. military

November 15, 2024

Palantir shares rally to fresh record on plans for move to Nasdaq

November 15, 2024

EV companies, battery makers urge Trump not to kill vehicle tax credits

November 15, 2024

Musk expands lawsuit against OpenAI, adding Microsoft and antitrust claims

November 15, 2024